• 322063
| Product name | B-Luc-EGFP SU-DHL-1 |
|---|---|
| Catalog number | 322063 |
| Aliases | NA |
| Tissue | Lymphoma |
| Disease | Large cell lymphoma; ddiffusehistiocytic lymphoma |
| Species | Human |
| Application | B-Luc-EGFP SU-DHL-1 cell line can be used to evalsuate anti-cancer drugs in large cell lymphoma or ddiffuse histiocytic lymphoma in vivo |
This B-Luc-EGFP SU-DHL-1 cell line expresses firefly luciferase as a marker of SU-DHL-1 cells. Fluorescence and EGFP could be detected in B-Luc-EGFP SU-DHL-1 cells.
Gene targeting strategy for B-Luc-EGFP SU-DHL-1 cells. The CMV promoter and luciferase-EGFP were inserted into the targeting vector used in the lentivirus system.
Luminescence signal intensity of B-Luc-EGFP SU-DHL-1 cells. Luminescence intensity was measured using the Bright-GloTM luciferase Assay. B-Luc-EGFP SU-DHL-1 cells have a strong luminescence signal. EGFP was detected in B-Luc-EGFP SU-DHL-1 cells. The 1-D10 clone of B-Luc-EGFP SU-DHL-1 cells can be used in vivo experiments.
B-Luc-EGFP SU-DHL-1 cells (5x106) were injected into the tail vein of wild-type B-NDG mice. Signal intensity and body weight were measured twice a week. (A) Imaging was performed twice a week. (B) Body weight (Mean ± SEM). B-Luc-EGFP SU-DHL-1 cells can be used for in vivo efficacy evalsuation.
